Patents for A61P 17 - Drugs for dermatological disorders (106,455)
06/2006
06/14/2006CN1259328C Isopamicin and its salt and their prepn
06/14/2006CN1259103C Prescription of medicine for preventing and treating fin rot of turbot
06/14/2006CN1259101C Medicine for treating tinea peids
06/14/2006CN1259098C Exterior-applied Chinese herbal medicine preparation for traumatic infection and inflammation-relieving acesodyne and its preparation method
06/14/2006CN1259093C Medicine for preventing and treating nipple chap and its preparing method
06/14/2006CN1259091C External paste for treating burn
06/14/2006CN1259087C Medicine for treating trauma and sores and its preparing process
06/14/2006CN1259061C Medicine for treating cindyloma acuminatum and its preparing process
06/14/2006CN1259059C Method for preparing placenta extract
06/14/2006CN1259052C Medicinal composition for treating burn and scald and preparing method
06/14/2006CN1259049C Composition for topical administration comprising an interleukin-2 inhibitor and an antimicrobial agent
06/14/2006CN1259034C Leech extract cosmetics and method for making same
06/14/2006CN1259032C Cosmetic or dermatological preparation for avoiding skin damage caused by peroxide
06/13/2006US7060827 Intermediates useful for making 2,4-pyrimidinediamine compounds
06/13/2006US7060732 Antiacne; skin disorders; packaged separately
06/13/2006US7060722 Proline derivatives and use thereof as drugs
06/13/2006US7060718 Novel arylsulfonanilide derivatives and their use as pharmacologically active agents. The compositions find particular use as pharmacological agents in the treatment of disease states, particularly cancer, psoriasis, vascular
06/13/2006US7060701 piperidines or piperazines 1-linked to a 1-(1-carbonylpiperidin-4-yl)piperidinyl- group through an optionally substituted methyl group; treating Human Immuno-deficiency Virus, solid organ transplant rejection, arthritis, rheumatoid arthritis, and multiple sclerosis
06/13/2006US7060700 Amide derivatives useful as inhibitors of the production of cytokines
06/13/2006US7060699 Aryl and heteroaryl diazabicycloalkanes, their preparation and use
06/13/2006US7060685 Benzylaminosulfonic Acid or portion or analogue linked to a carbohydrate or glycomimetic for modulating processes mediated by selectin binding such as autoimmune and inflammatory diseases, shock and reperfusion injuries
06/13/2006US7060305 extracts contain higher concentration of isoflavones; used to treat erectile dysfunction or malfunction
06/13/2006US7060298 Comprises biocompatible hydrophilic cationic microparticles and cell adhesion promoter implanted into the lower esophageal sphincter
06/13/2006US7060289 Topical glycopyrrolate product
06/13/2006CA2366623C Resorcinol composition
06/09/2006CA2489851A1 Composition for treating psoriasis
06/08/2006WO2006060617A1 Ascomycin crystalline forms and preparation thereof
06/08/2006WO2006060615A1 Non-hygroscopic and powdery amorphous pimecrolimus
06/08/2006WO2006060614A1 Methods for preparing pimecrolimus
06/08/2006WO2006060475A1 Method for treating skin disorders with xanthophylls
06/08/2006WO2006060470A1 Antioxidant dietary supplement compositions and methods for maintaining healthy skin
06/08/2006WO2006059801A1 7-membered ring compound, process for producing the same, and medicinal use thereof
06/08/2006WO2006059768A1 9,10-secopregnane derivative and medicine
06/08/2006WO2006059712A1 Monoclonal antibody binding to human steroid sulfatase
06/08/2006WO2006059329A1 Platelet-derived microparticles for therapy
06/08/2006WO2006058940A1 Use of amygdalin analogues for the treatment of psoriasis
06/08/2006WO2006035319A3 Methods of using chimeric coiled-coil molecule
06/08/2006WO2006010503A3 Rxr antagonists in the treatment of inflammatory diseases
06/08/2006WO2005116067A3 Msh-agonist tripeptide conjugates
06/08/2006US20060122392 Tri-heterocyclic compounds and a pharmaceutical comprising them as an active ingredient
06/08/2006US20060122390 Boronic ester and acid compounds, synthesis and uses
06/08/2006US20060122374 Albumin-fused anti-angiogenesis peptides
06/08/2006US20060122370 Specific binding agents of human angiopoietin-2
06/08/2006US20060122249 Condensed heterocyclic pyrazole derivatives as kinase inhibitors
06/08/2006US20060122243 Antiallergic
06/08/2006US20060122242 2-Aryloxy-2-arylalkanoic acids for diabetes and lipid disorders
06/08/2006US20060122234 Substituted thienyl-hydroxamic acids as histone deacetylase inhibitors
06/08/2006US20060122221 N-[4-methyl-3-(3-piperidin-4-yl-1,2-benzisoxazol-6-yl)phenyl]-2-pyrrolidin-1-ylisonicotinamide; rheumatoid arthritis
06/08/2006US20060122200 Use and application of a pharmaceutical composition containing a mixture of natural- origin heterocyclical guanidine, for cosmetology, wound healing, focal dystonia and muscular spasm- related clinical pathologies
06/08/2006US20060122176 such as 5-(1,3-benzodioxol-5-ylmethylene)-1,3-thiazolidine-2,4-dione, used for the treatment and/or prophylaxis of autoimmune, cardiovascular or neurodegenerative disorders, inflammatory or kidney diseases, bacterial or viral infections, platelet aggregation, cancer, transplant rejection or lung injuries
06/08/2006US20060122173 Il-8 receptor antagonists
06/08/2006US20060122149 Extraction and purification method for cereal beta-glucan
06/08/2006US20060122101 Drug for preventing, regulating or treating adhesion
06/08/2006US20060122100 Melanin extinguisher
06/08/2006US20060121583 New method for synthesizing ceramide-type compounds
06/08/2006US20060121514 Prostacyclin-stimulating Factor-2
06/08/2006US20060121091 Cellular uptake of bioactive agents
06/08/2006US20060121069 Compositions and methods for treating hair loss using oximyl and hydroxylamino prostaglandins
06/08/2006US20060121025 VEGF-related protein
06/08/2006US20060121015 Probiotic bifidobacterium strains
06/08/2006US20060120985 Novel ampiphilic derivatives of alpha-c-phenyl-n-tert-butyl nitrone
06/08/2006US20060120977 Controlled delivery system of antifungal and keratolytic agents for local treatment of fungal infections of the nail and surrounding tissues
06/08/2006DE102004055932A1 Zubereitung enthaltend oxidierte Flavonoid-Derivate Preparation containing oxidized flavonoid derivatives
06/08/2006CA2589638A1 7-membered ring compound and method of production and pharmaceutical application thereof
06/08/2006CA2589633A1 Method for treating skin disorders with xanthophylls
06/08/2006CA2586865A1 Antioxidant dietary supplement compositions and methods for maintaining healthy skin
06/08/2006CA2584430A1 Methods for preparing pimecrolimus
06/08/2006CA2584365A1 Ascomycin crystalline forms and preparation thereof
06/08/2006CA2584358A1 Non-hygroscopic and powdery amorphous pimecrolimus
06/07/2006EP1666481A2 Optical resolution of (1-benzyl-4-methylpiperidin-3-yl)-methylamine and the use thereof for the preparation of pyrrolo[2,3]pyrimidine derivatives as protein kinases inhibitors
06/07/2006EP1666480A1 Aryl or Heteroaryl Fused Imidazole Compounds as intermediates for Anti-Inflammatory And Analgesic Agents.
06/07/2006EP1666473A1 Carboxylic acid compounds and medicinal compositions containing the same as the active ingredient
06/07/2006EP1666036A1 Hair restorer
06/07/2006EP1664798A2 Non-peptide agonists and antagonists of adrenomedullin and gastrin releasing peptide
06/07/2006EP1664003A1 Haloalkyl containing compounds as cysteine protease inhibitors
06/07/2006EP1663958A2 Haloalkyl containing compounds as cysteine protease inhibitors
06/07/2006EP1663931A1 Benzotropolone derivatives and modulation of inflammatory response
06/07/2006EP1663285A2 Use of peptidic conjugates for preparing compositions for alopecia preventive and curative treatment
06/07/2006EP1663284A1 Compositions and methods for treatment of psoriasis
06/07/2006EP1663195A2 Taurine bromamine for inhibiting pathogenic bacteria and fungi growth as well as in a microbicidal composition
06/07/2006EP1663154A1 i MAHONIA /i i AQUIFOLIUM /i EXTRACT, EXTRACTION PROCESS AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME
06/07/2006EP1663132A1 Anhydrous topical formulation for polyphenols
06/07/2006EP1663111A2 Delivery of physiologixal agents with in-situ gels comprising anionic polysaccharides
06/07/2006EP1663104A2 Porifera-based therapeutic compositions for treating and preventing skin diseases
06/07/2006EP1663061A2 Use of melatonin-containing oral supplement with animals
06/07/2006EP1492789B1 Tropane derivatives as ccr5 modulators
06/07/2006EP1421075B1 Piperidine derivatives useful as ccr5 antagonists for the treatment of hiv
06/07/2006EP1414487B1 Use of thrombin-derived peptides for the therapy of chronic dermal ulcers
06/07/2006EP1406878B1 4-(benzylidene-amino)-3-(methylsulfanyl)-4h-(1, 2, 4) triazin-5-one derivatives having a pde-iv inhibiting and tnf-antagonistic effect for the treatment of cardiac diseases and allergies
06/07/2006EP1378510B1 Triazaspiro (5.5) undecane derivatives and drugs containing the same as the active ingredient
06/07/2006EP1368355B1 Substituted pyrazolopyrimidines and thiazolopyrimidines
06/07/2006EP1364023B1 Gene highly expressed in cartilage tissues
06/07/2006EP1311478B1 Novel (thio)urea compounds and the pharmaceutical compositions containing the same
06/07/2006EP1309559B1 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists
06/07/2006EP1200039B1 Emulsifier-free finely dispersed water-in-oil-type systems
06/07/2006EP1071463B1 Methods and compositions using terfenadine metabolites in combination with leukotriene inhibitors
06/07/2006CN1784426A Antibody targeted at antigen specific to cancer
06/07/2006CN1784398A 4-(2-furoyl)aminopiperidine compound useful as therapeutic agent for itching
06/07/2006CN1784251A Method for the production of flavonoid-containing compositions and use thereof
06/07/2006CN1784215A Melanogenesis promoter and melanogenesis promoter composition